KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.N Engl J MedPMID 40162636无 PMCID2025-Apr-100.90This is a Phase III randomized trial in humans with active cancer. It has a time-to-event primary endpoint (recurrent VTE). However, the intervention (apixaban) is an anticoagulant used for VTE prevention, not a cancer treatment drug. The study is not a drug intervention trial for oncology treatment efficacy (e.g., OS, PFS, DFS) but for a supportive/complication-prevention endpoint. Therefore, it does not meet the 'drug intervention' criterion for an oncology efficacy trial as defined.待处理
Bireociclib plus fulvestrant for HR+/HER2- advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysis.Nat CommunPMID 40204778PMC119823592025-Apr-090.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Laboratory markers predicting tofacitinib efficacy in Japanese patients with rheumatoid arthritis: A pooled analysis of Phase 2/3 randomised controlled clinical trials.Mod RheumatolPMID 39657989无 PMCID2025-Apr-080.98未发现恶性肿瘤人群证据。待处理
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 study.Mod RheumatolPMID 39801286无 PMCID2025-Apr-080.98未发现恶性肿瘤人群证据。待处理
Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV.AIDS Res TherPMID 40197415PMC119781002025-Apr-070.98未发现恶性肿瘤人群证据。待处理
Assessment of heterogeneity according to hospital or medical experience factors in outcomes of chemotherapy for advanced biliary tract cancer: a post-hoc analysis of JCOG1113.Jpn J Clin OncolPMID 39775866PMC119736342025-Apr-060.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。已完成
First-line pembrolizumab-axitinib versus sunitinib in metastatic RCC: subgroup analysis of patients enrolled in the phase 3 KEYNOTE-426 in Eastern Asia.Jpn J Clin OncolPMID 39815637PMC120428002025-Apr-060.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。已完成
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitis.J Crohns ColitisPMID 40168091PMC119767222025-Apr-040.98未发现恶性肿瘤人群证据。待处理
Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.N Engl J MedPMID 39602624无 PMCID2025-Apr-030.98未发现恶性肿瘤人群证据。待处理
Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours.N Engl J MedPMID 40174223无 PMCID2025-Apr-030.98未发现恶性肿瘤人群证据。待处理
Impact of RSV Prevention in Infancy on Prevalence of Asthma Among 9-14-Year-old Native American Children in the Southwest United States.Pediatr Infect Dis JPMID 40208934无 PMCID2025-Apr-030.98未发现恶性肿瘤人群证据。待处理
Health-related quality of life (HRQL) assessments in a 52-week, double-blind, randomized, placebo-controlled phase III study of resmetirom (MGL-3196) in patients with metabolic dysfunction-associated steatohepatitis (MASH) and fibrosis.HepatologyPMID 39250515无 PMCID2025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of filgotinib in patients with moderately active rheumatoid arthritis and an inadequate response to methotrexate.Rheumatology (Oxford)PMID 39331638PMC119630782025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Weight and Metabolic Changes With Long-Acting Cabotegravir and Rilpivirine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.J Acquir Immune Defic SyndrPMID 39676239PMC118417242025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.Int J Cancer疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 3 张 PMC Figure,均未识别为 KM 图:FIGURE 1:森林图/亚组分析图;FIGURE 2:森林图/亚组分析图;FIGURE 3:非 KM 图。PMID 39739622PMC117894512025-Apr-010.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。无 KM 图
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY Study.J GlaucomaPMID 39750078PMC119526862025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study.J RheumatolPMID 39814441无 PMCID2025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.J Nucl MedPMID 40015915无 PMCID2025-Apr-010.85The study is a randomized Phase II/III oncology trial with time-to-event endpoints, but the intervention described is a radiotherapy dose modification strategy (boost vs. standard) without a specific drug-containing arm. The abstract mentions radiochemotherapy in the methods but does not specify any drug intervention in the analyzed groups or results, making drug intervention unclear and not explicitly established. Therefore, it is excluded.待处理
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.JAMA OphthalmolPMID 40048178PMC118868662025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial.JAMA OphthalmolPMID 40048197PMC118868692025-Apr-010.98未发现恶性肿瘤人群证据。待处理
Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration-sensitive prostate cancer.CancerPMID 40106307PMC119221672025-Apr-010.70The record describes a subgroup/heterogeneity analysis of a Phase III randomized trial (TITAN) comparing apalutamide vs. placebo. While it meets several criteria (oncology, human, randomized, Phase III, time-to-event endpoints), it is not the primary or definitive result report of the trial. The report type is 'subgroup', which is excluded per the rules.已完成
Subgroup analysis by sex and baseline BMI in people with a BMI ≥27 kg/m2 in the phase 2 trial of survodutide, a glucagon/GLP-1 receptor dual agonist.Diabetes Obes MetabPMID 39821928PMC118850882025-Apr0.98未发现恶性肿瘤人群证据。待处理
The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials.Eur Urol Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39034169无 PMCID2025-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Health-related quality of life in cutaneous T-cell lymphoma: A post hoc analysis of a phase 3 trial in mycosis fungoides and Sézary syndrome.J Eur Acad Dermatol VenereolPMID 39315857PMC119340172025-Apr0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial.Eur Urol OncolPMID 39384451无 PMCID2025-Apr0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration: A Phase III Randomized Trial.Ophthalmol RetinaPMID 39389463无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Retinal Fluid and Thickness Fluctuations in Archway Trial for Port Delivery System with Ranibizumab versus Monthly Ranibizumab Injections.Ophthalmol RetinaPMID 39447871无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine versus a quadrivalent meningococcal conjugate vaccine in adults in India: an observer-blind, randomised, active-controlled, phase 2/3 study.Lancet Infect DisPMID 39521012无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD.Am J Kidney DisPMID 39521398无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab Trials.OphthalmologyPMID 39581330无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
A randomized phase III study to compare efficacy and safety of BAT2206 (proposed ustekinumab biosimilar) with reference ustekinumab in patients with moderate to severe plaque psoriasis.J Am Acad DermatolPMID 39592058无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Dietary Habits of Individuals With Primary Sclerosing Cholangitis-Poor Fat-Soluble Vitamin Intake and Dietary Quality.Liver IntPMID 39601354PMC119072172025-Apr0.98未发现恶性肿瘤人群证据。待处理
Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial.Lancet Infect DisPMID 39608389无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLC.J Thorac Oncol疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 当前未获得可用 PubMed/PMC Figure 图源,建议后续从出版商页补图源。PMID 39622410无 PMCID2025-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。无 KM 图
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.J Clin OncolPMID 39637340PMC119492052025-Apr1.00命中用户提供的消化道肿瘤阳性参考集。部分完成
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR.J Heart Lung TransplantPMID 39645016无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.Liver IntPMID 39648559PMC119072242025-Apr0.98未发现恶性肿瘤人群证据。待处理
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma.Ann OncolPMID 39672382PMC124590812025-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP).Int J Infect DisPMID 39674398无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Association that Neuroimaging and Clinical Measures Have with Change in Arm Impairment in a Phase 3 Stroke Recovery Trial.Ann NeurolPMID 39676623无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer.J Thorac OncolPMID 39694415无 PMCID2025-Apr0.85The study is a Phase III randomized trial in human oncology, but it does not meet two key eligibility criteria: (1) The primary endpoint is time to treatment initiation (TTI), which is a diagnostic/process measure, not a clinical efficacy time-to-event endpoint (e.g., OS, PFS). (2) The intervention is a diagnostic liquid biopsy procedure versus standard diagnostic care; there is no experimental drug-containing intervention.待处理
Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial.Ann OncolPMID 39706335PMC121844332025-Apr0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。已完成
Glepaglutide, a Long-Acting Glucagon-like Peptide-2 Analogue, Reduces Parenteral Support in Patients With Short Bowel Syndrome: A Phase 3 Randomized Controlled Trial.GastroenterologyPMID 39708985无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: Week 52 results from a phase 3b, randomized, double-blind, placebo-controlled trial.J Am Acad DermatolPMID 39722400无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial.Diabetes Obes MetabPMID 39781601无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials.Diabetes Obes MetabPMID 39789843PMC118850852025-Apr0.98未发现恶性肿瘤人群证据。待处理
Alkalinised lidocaine as an anaesthetic before onabotulinumtoxinA injections. a randomised trial.BJU IntPMID 39797697PMC119136032025-Apr0.98未发现恶性肿瘤人群证据。待处理
Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser Trabeculoplasty.Am J OphthalmolPMID 39800203无 PMCID2025-Apr0.98未发现恶性肿瘤人群证据。待处理
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial.DiabetologiaPMID 39820580PMC119500202025-Apr0.98未发现恶性肿瘤人群证据。待处理
Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia.Am Heart JPMID 39826701PMC126966912025-Apr0.98未发现恶性肿瘤人群证据。待处理